| Literature DB >> 35647648 |
Alessandra Piccirilli1, Sabrina Cherubini1, Giuseppe Celenza1, Gian Maria Rossolini2,3, Fabrizia Brisdelli1, Bernardetta Segatore1, Luigi Principe4, Francesco Luzzaro4, Lilia Andriani5, Gianfranco Amicosante1, Mariagrazia Perilli1.
Abstract
KPC-53 enzyme is a natural KPC variant which showed a duplication of L167E168 residues in the Ω-loop structure. The blaKPC-53 gene was cloned both into pBC-SK and pET-24a vectors, and the recombinant plasmids were transferred by transformation in Escherichia coli competent cells to evaluate the antimicrobial susceptibility and to produce the enzyme. Compared to KPC-3, the KPC-53 was less stable and showed a dramatic reduction of kcat and kcat/Km versus several β-lactams, in particular carbapenems. Indeed, a 2,000-fold reduction was observed in the kcat values of KPC-53 for imipenem and meropenem. Concerning inhibitors, KPC-53 was susceptible to tazobactam and clavulanic acid but maintained resistance to avibactam. The molecular modeling indicates that the L167E168 duplication in KPC-53 modifies the interactions between residues involved in the catalytic pocket, changing the flexibility of the Ω-loop, which is directly coupled with the catalytic properties of the KPC enzymes.Entities:
Keywords: KPC-53; carbapenemase; serine-β-lactamase
Mesh:
Substances:
Year: 2022 PMID: 35647648 PMCID: PMC9211410 DOI: 10.1128/aac.02402-21
Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN: 0066-4804 Impact factor: 5.938